| Application no. and date | 14800179.5 (espacenet) (Federated) (European Patent Register), 20141003 | | Patent/reg. no. and date | DK/EP 3052628, 20200226 | | Publication date | 20160810 | | Priority no. and date | US 201361887288 P, 20131004, US 201461983720 P, 20140424 | | EP pub. no. and date |
EP 3052628 20160810 | | Effective date | | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 300 Third Street
Cambridge, MA 02142, US,
Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place
New York, NY 10029, US | | Applicant ref. no. | 1553948 | | Inventor | DESNICK, Robert, J., 170 East 93rd Street
New York, NY 10128, US,
BETTENCOURT, Brian, 300 Third Street
Cambridge, MA 02142, US,
YASUDA, Makiko, 100 Overlook Terrace
Apartment 612
New York, NY 10040, US,
FITZGERALD, Kevin, 300 Third Street
Cambridge, MA 02142, US,
QUERBES, William, 300 Third Street
Cambridge, MA 02142, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , A61K 31/713 (2006.01) , A61P 3/00 (2006.01) , C12N 15/113 (2010.01) | | Title | SAMMENSÆTNINGER OG FREMGANGSMÅDER TIL INHIBERING AF EKSPRESSION AF ALAS1-GENET | | Int. application no. | US2014059160 | | Int. publication no. | WO2015051318 | | Related patent (certificate) | CA 2020 00042 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
